Immunethep announces research collaboration with MSD
16 February 2021
PRESS RELEASE
The goal of the research is to evaluate bacterial glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a suitable virulence factor in developing potential immunotherapies for the treatment and/or prevention of bacterial infections.
Download the Press Release below:
Press_Release_IMTP_MSD_eng.pdf
Press_Release_IMTP_MSD_pt.pdf
